同性哈灵顿:机制,临床应用和研究进展
Wen Wang1, Lan He2,3, Ting Lin1,2,3
1Graduate School, Hunan University of Chinese Medicine, Changsha, China.
Frontiers in oncology
|February 14, 2025
概括
荷莫哈林顿因 (HHT) 通过诱导细胞亡和抑制细胞生长,在治疗血液癌症方面表现有前途. 研究正在探索药物输送系统,以改善HHT.
科学领域:
- 药理学 药理学是指药理学的学科.
- 自然产品 化学 化学
- 在瘤学瘤学.
背景情况:
- 荷莫哈林顿因 (HHT) 是一种天然类化合物,在血液性恶性瘤中已证明有效.
- 通过诱导亡,细胞循环停止和抑制细胞迁移,HHT表现出抗癌性质.
- 此外,HHT还具有免疫调节,抗病毒,抗纤维和神经保护作用.
研究的目的:
- 系统地审查Homoharringtonine (HHT) 的药理机制.
- 探索HHT在治疗血液性恶性瘤中的疗效.
- 讨论克服HHT局限性的策略,例如低生物可用性和副作用.
主要方法:
- 对Homoharringtonine的药理作用进行系统的文献综述.
- 对血液恶性瘤中HHT的临床试验数据的分析.
- 对新型药物递送系统 (纳米颗粒,脂质体) 和化学修饰进行审查,以提高HHT生物可用性和向性.
主要成果:
- 荷莫哈林顿因有效治疗血液恶性瘤,如急性髓性白血病和慢性髓性白血病.
- 低生物可用性和潜在的副作用是HHT临床使用的关键挑战.
- 先进的药物递送系统和化学修饰显著改善了HHT的体内生物利用性,向性,并降低了毒性.
结论:
- 荷莫哈林顿因是一种强大的天然类化合物,在瘤学和其他领域具有广泛的治疗潜力.
- 提高HHT生物可用性和输送的策略对于其更广泛的临床应用至关重要.
- 涉及HHT的组合疗法为改善癌症治疗结果提供了有希望的途径.
相关概念视频
01:25Adrenergic Agonists: Indirect-Acting Agents
1.5K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.5K
01:29Drugs Affecting Neurotransmitter Synthesis
1.2K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.2K
01:25Drug-Receptor Interaction: Agonist
2.3K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.3K
01:21Drugs Affecting Neurotransmitter Release or Uptake
926
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
926
01:21Antipsychotic Drugs: Typical and Atypical Agents
149
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
149
01:23Antidepressant Drugs: MAOIs and Other Agents
181
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
181